Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Often, the disease process manifested in a certain rare disease is strikingly similar to the disease process observed in a common disease. This work ties the lessons learned about rare diseases to our understanding of common ones.
This book provides an up-to-date monograph on the drug discovery and regulatory elements of therapeutics used to treat rare or "orphan" diseases.
This book provides a broad overview of rare disease drug development.
One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient groups.The journey from application of an orphan drug ...
This book aims to help all of them to address topics like health care policies, societal issues and clinical and experimental research.
Innovative Methods for Rare Disease Drug Development focuses on biostatistical applications in terms of design and analysis in pharmaceutical research and development from both regulatory and scientific (statistical) perspectives.
This book illustrates, in a comprehensive manner, the most crucial principles involved in pharmacology and allied sciences.
Global Pediatric Development of Drugs, Biologics, and Medical Devices
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes.
Diagnosis , contact lens prescribing and care of the keratoconus patient . In : Clinical practice in contact lenses . Boston : Butterworth - Heineman , 1999 . RESOURCES 288 , 307 , 355 life , infantile nystagmus , a variety of retinal ...